• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

-(1,3,4-恶二唑-2-基)苯甲酰胺类化合物作为抗菌剂对抗...

-(1,3,4-Oxadiazol-2-yl)Benzamides as Antibacterial Agents against .

机构信息

Chemistry Department, Institute for Drug Discovery, Purdue University, West Lafayette, IN 47907, USA.

Department of Comparative Pathobiology, Purdue University College of Veterinary Medicine, West Lafayette, IN 47907, USA.

出版信息

Int J Mol Sci. 2021 Feb 28;22(5):2427. doi: 10.3390/ijms22052427.

DOI:10.3390/ijms22052427
PMID:33671065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7957578/
Abstract

The Centers for Disease Control and Prevention (CDC) recognizes as an urgent-threat Gram-negative bacterial pathogen. Additionally, resistance to frontline treatment (dual therapy with azithromycin and ceftriaxone) has led to the emergence of multidrug-resistant , which has caused a global health crisis. The drug pipeline for has been severely lacking as new antibacterial agents have not been approved by the FDA in the last twenty years. Thus, there is a need for new chemical entities active against drug-resistant . Trifluoromethylsulfonyl (SOCF), trifluoromethylthio (SCF), and pentafluorosulfanyl (SF) containing -(1,3,4-oxadiazol-2-yl)benzamides are novel compounds with potent activities against Gram-positive bacterial pathogens. Here, we report the discovery of new -(1,3,4-oxadiazol-2-yl)benzamides ( and ) with highly potent activity against . Additionally, these new compounds were shown to have activity against clinically important Gram-positive bacteria, such as methicillin-resistant (MRSA), vancomycin-resistant enterococci (VRE), and (minimum inhibitory concentrations (MICs) as low as 0.25 µg/mL). Both compounds were highly tolerable to human cell lines. Moreover, showed an outstanding ability to permeate across the gastrointestinal tract, indicating it would have a high systemic absorption if used as an anti-gonococcal therapeutic.

摘要

疾病控制与预防中心(CDC)将淋病奈瑟菌视为一种紧急威胁的革兰氏阴性细菌病原体。此外,对一线治疗(阿奇霉素和头孢曲松联合治疗)的耐药性导致了多药耐药淋病奈瑟菌的出现,这引发了一场全球卫生危机。过去二十年,新的抗菌药物未获 FDA 批准,因此,针对耐药淋病奈瑟菌的药物研发管道严重匮乏。含三氟甲磺酰基(SOCF)、三氟甲硫基(SCF)和五氟硫基(SF)的 -(1,3,4-恶二唑-2-基)苯甲酰胺是一类新型化合物,对革兰氏阳性细菌病原体具有很强的活性。在这里,我们报告了一类新的 -(1,3,4-恶二唑-2-基)苯甲酰胺(和 )的发现,它们对淋病奈瑟菌具有很强的活性。此外,这些新化合物对临床上重要的革兰氏阳性细菌也具有活性,如耐甲氧西林金黄色葡萄球菌(MRSA)、万古霉素耐药肠球菌(VRE)和化脓性链球菌(MIC 值低至 0.25 µg/mL)。这两种化合物对人细胞系都具有很高的耐受性。此外, 显示出出色的穿透胃肠道的能力,如果将其用作抗淋病奈瑟菌的治疗药物,它将具有很高的全身吸收能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392a/7957578/4bfc0b42db99/ijms-22-02427-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392a/7957578/8fa70057dbc6/ijms-22-02427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392a/7957578/f5637cd5dc5c/ijms-22-02427-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392a/7957578/4bfc0b42db99/ijms-22-02427-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392a/7957578/8fa70057dbc6/ijms-22-02427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392a/7957578/f5637cd5dc5c/ijms-22-02427-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392a/7957578/4bfc0b42db99/ijms-22-02427-g002.jpg

相似文献

1
-(1,3,4-Oxadiazol-2-yl)Benzamides as Antibacterial Agents against .-(1,3,4-恶二唑-2-基)苯甲酰胺类化合物作为抗菌剂对抗...
Int J Mol Sci. 2021 Feb 28;22(5):2427. doi: 10.3390/ijms22052427.
2
Comparative Studies to Uncover Mechanisms of Action of -(1,3,4-Oxadiazol-2-yl)benzamide Containing Antibacterial Agents.-(1,3,4-恶二唑-2-基)苯甲酰胺类含抗菌剂作用机制的比较研究。
ACS Infect Dis. 2022 Apr 8;8(4):865-877. doi: 10.1021/acsinfecdis.1c00613. Epub 2022 Mar 17.
3
Potent trifluoromethoxy, trifluoromethylsulfonyl, trifluoromethylthio and pentafluorosulfanyl containing (1,3,4-oxadiazol-2-yl)benzamides against drug-resistant Gram-positive bacteria.含三氟甲氧基、三氟甲磺酰基、三氟甲硫基和五氟硫基的强效(1,3,4-恶二唑-2-基)苯甲酰胺对耐药革兰氏阳性菌的作用
RSC Med Chem. 2019 Dec 16;11(1):102-110. doi: 10.1039/c9md00391f. eCollection 2020 Jan 1.
4
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.淋病奈瑟菌抗菌药物敏感性监测 - 淋球菌分离株监测项目,美国 27 个监测点,2014 年。
MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.
5
Efficacy of Gentamicin Alone and in Combination with Ceftriaxone, Ertapenem, and Azithromycin against Multidrug-Resistant Neisseria gonorrhoeae.单独使用庆大霉素以及联合使用头孢曲松、厄他培南和阿奇霉素对抗耐多药淋病奈瑟菌的疗效。
Microbiol Spectr. 2021 Oct 31;9(2):e0018121. doi: 10.1128/Spectrum.00181-21. Epub 2021 Oct 20.
6
Investigation of auranofin and gold-containing analogues antibacterial activity against multidrug-resistant Neisseria gonorrhoeae.调查金诺芬和含金类似物对耐多药淋病奈瑟菌的抗菌活性。
Sci Rep. 2020 Mar 27;10(1):5602. doi: 10.1038/s41598-020-62696-3.
7
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.N-(1,3,4-噁二唑-2-基)苯甲酰胺类似物,抗耐甲氧西林和万古霉素的细菌的抑菌剂。
Eur J Med Chem. 2018 Jul 15;155:797-805. doi: 10.1016/j.ejmech.2018.06.023. Epub 2018 Jun 15.
8
Antimicrobial Activity of Auranofin, Cannabidivarin, and Tolfenamic Acid against Multidrug-Resistant Neisseria gonorrhoeae.金诺芬、大麻二酚和托芬那酸对耐多药淋病奈瑟菌的抗菌活性。
Microbiol Spectr. 2022 Dec 21;10(6):e0395222. doi: 10.1128/spectrum.03952-22. Epub 2022 Nov 9.
9
A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant and Other High-Threat Pathogens.一种新型的口腔 GyrB/ParE 双重结合抑制剂,对多药耐药和其他高威胁病原体有效。
Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0041422. doi: 10.1128/aac.00414-22. Epub 2022 Aug 16.
10
Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.2009-2019 年东欧白俄罗斯淋病奈瑟菌分离株的抗菌药物耐药性和淋病治疗情况。
BMC Infect Dis. 2021 Jun 2;21(1):520. doi: 10.1186/s12879-021-06184-7.

引用本文的文献

1
A novel peptide mimetic, brilacidin, for combating multidrug-resistant Neisseria gonorrhoeae.一种新型肽模拟物——布立西丁,用于对抗多重耐药淋病奈瑟菌。
PLoS One. 2025 Jun 5;20(6):e0325722. doi: 10.1371/journal.pone.0325722. eCollection 2025.
2
Optimization of Ethoxzolamide Analogs with Improved Pharmacokinetic Properties for Efficacy against .优化具有改善药代动力学特性的乙氧唑胺类似物,以提高对 的疗效。
J Med Chem. 2024 Sep 12;67(17):15537-15556. doi: 10.1021/acs.jmedchem.4c01187. Epub 2024 Aug 14.
3
Inhibition of pathogenic bacterial carbonic anhydrases by monothiocarbamates.

本文引用的文献

1
-Butylphenylthiazoles with an oxadiazole linker: a novel orally bioavailable class of antibiotics exhibiting antibiofilm activity.带有恶二唑连接基的丁基苯基噻唑:一类新型具有口服生物利用度且展现出抗生物膜活性的抗生素。
RSC Adv. 2019 Feb 26;9(12):6770-6778. doi: 10.1039/c8ra10525a. eCollection 2019 Feb 22.
2
Potent trifluoromethoxy, trifluoromethylsulfonyl, trifluoromethylthio and pentafluorosulfanyl containing (1,3,4-oxadiazol-2-yl)benzamides against drug-resistant Gram-positive bacteria.含三氟甲氧基、三氟甲磺酰基、三氟甲硫基和五氟硫基的强效(1,3,4-恶二唑-2-基)苯甲酰胺对耐药革兰氏阳性菌的作用
RSC Med Chem. 2019 Dec 16;11(1):102-110. doi: 10.1039/c9md00391f. eCollection 2020 Jan 1.
3
单硫代氨基甲酸盐对致病性细菌碳酸酐酶的抑制作用。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2284119. doi: 10.1080/14756366.2023.2284119. Epub 2023 Nov 23.
4
Substituted salicylic acid analogs offer improved potency against multidrug-resistant Neisseria gonorrhoeae and good selectivity against commensal vaginal bacteria.取代水杨酸类似物提高了对耐多药淋病奈瑟菌的效力,对共生阴道细菌具有良好的选择性。
Sci Rep. 2023 Sep 2;13(1):14468. doi: 10.1038/s41598-023-41442-5.
5
Molecular Mechanisms of Drug Resistance and Epidemiology of Multidrug-Resistant Variants of .多药耐药变体的耐药机制和流行病学。
Int J Mol Sci. 2022 Sep 10;23(18):10499. doi: 10.3390/ijms231810499.
6
Mechanistic Studies and Efficacy of an Oxadiazole-Containing Antibiotic.含恶二唑的抗生素的作用机制研究及疗效
J Med Chem. 2022 May 12;65(9):6612-6630. doi: 10.1021/acs.jmedchem.1c02034. Epub 2022 Apr 28.
7
Auranofin exerts antibacterial activity against Neisseria gonorrhoeae in a female mouse model of genital tract infection.金诺芬在女性生殖道感染小鼠模型中对淋病奈瑟菌具有抗菌活性。
PLoS One. 2022 Apr 21;17(4):e0266764. doi: 10.1371/journal.pone.0266764. eCollection 2022.
8
Comparative Studies to Uncover Mechanisms of Action of -(1,3,4-Oxadiazol-2-yl)benzamide Containing Antibacterial Agents.-(1,3,4-恶二唑-2-基)苯甲酰胺类含抗菌剂作用机制的比较研究。
ACS Infect Dis. 2022 Apr 8;8(4):865-877. doi: 10.1021/acsinfecdis.1c00613. Epub 2022 Mar 17.
9
Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives.1,3,4-恶二唑衍生物的抗菌活性。
Int J Mol Sci. 2021 Jun 29;22(13):6979. doi: 10.3390/ijms22136979.
Fetal bovine serum albumin inhibits antimicrobial peptide activity and binds drug only in complex with α1-antitrypsin.
胎牛血清白蛋白抑制抗菌肽活性,且仅在与 α1-抗胰蛋白酶形成复合物时结合药物。
Sci Rep. 2021 Jan 14;11(1):1267. doi: 10.1038/s41598-020-80540-6.
4
Ultrapotent Inhibitor of Growth, Which Suppresses Recurrence .超强生长抑制剂,抑制复发。
J Med Chem. 2020 Oct 22;63(20):11934-11944. doi: 10.1021/acs.jmedchem.0c01198. Epub 2020 Oct 6.
5
Multiple ways to kill bacteria via inhibiting novel cell wall or membrane targets.通过抑制新型细胞壁或细胞膜靶点来杀死细菌的多种方法。
Future Med Chem. 2020 Jul;12(13):1253-1279. doi: 10.4155/fmc-2020-0046. Epub 2020 Jun 15.
6
Repurposing Fenamic Acid Drugs To Combat Multidrug-Resistant Neisseria gonorrhoeae.重新利用非那酸类药物来对抗耐多药淋病奈瑟菌。
Antimicrob Agents Chemother. 2020 Jun 23;64(7). doi: 10.1128/AAC.02206-19.
7
Repurposing the Antiamoebic Drug Diiodohydroxyquinoline for Treatment of Clostridioides difficile Infections.抗阿米巴药物二碘羟基喹啉再利用治疗艰难梭菌感染。
Antimicrob Agents Chemother. 2020 May 21;64(6). doi: 10.1128/AAC.02115-19.
8
Investigation of auranofin and gold-containing analogues antibacterial activity against multidrug-resistant Neisseria gonorrhoeae.调查金诺芬和含金类似物对耐多药淋病奈瑟菌的抗菌活性。
Sci Rep. 2020 Mar 27;10(1):5602. doi: 10.1038/s41598-020-62696-3.
9
Synthesis and antimicrobial evaluation of new halogenated 1,3-Thiazolidin-4-ones.新型含卤 1,3-噻唑烷-4-酮的合成及抗菌评价。
Bioorg Chem. 2020 Jan;95:103517. doi: 10.1016/j.bioorg.2019.103517. Epub 2019 Dec 17.
10
Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria.开发苯并咪唑衍生物作为抗菌药物及其与黏菌素对革兰氏阴性菌的协同作用。
Eur J Med Chem. 2020 Jan 15;186:111850. doi: 10.1016/j.ejmech.2019.111850. Epub 2019 Nov 5.